Vasoconstriction may reflect the absence of demonstrated vasodilatory T3 effects on vascular smooth muscle cells or may be the result of a higher circulating noradrenaline level and increased AT1 ...

infectious disease receptor binding medical decision analysis http ... The detected cell types included ciliated, alveolar type 1 (AT1) and -AT2 cells, along with fibroblast, muscle and endothelial ...

Buloxibutid is a first-in-class angiotensin II type 2 (AT2) receptor agonist that activates an upstream mechanism to drive alveolar repair, resolve fibrosis, and promote pulmonary vascular function.

One of the most significant surprises of 2024 was the plan announced by the Australian Prudential Regulation Authority’s (APRA) to phase out AT1 hybrids issued by banks. This change raises a number of ...

Humanwell Healthcare (Group) Co. Ltd. has developed new heterocyclic compounds acting as angiotensin AT2 receptor antagonists reported to be useful for the treatment of neuropathy and neuropathic pain ...

AIB said the "Additional Tier 1" (AT1) perpetual bond further supports the lender in meeting its regulatory capital requirements. It also marks the first Euro AT1 deal of the year in Europe ...

In this article the role of a family of pH-sensing G protein-coupled receptors (GPCRs) in tumor biology is reviewed. Recent studies show that the pH-sensing GPCRs, including GPR4, GPR65 (TDAG8), GPR68 ...

The oxytocin receptor (OXTR) is a G protein-coupled receptor with a diverse repertoire of intracellular signaling pathways, which are activated in response to binding oxytocin (OXT) and a similar ...